Stay ahead in the ever-evolving landscape of pharmaceutical regulation with our expert guidance. From compliance with stringent UK and EU directives to navigating global market entry requirements, we provide the essential tools and insights legal professionals need to advise clients confidently. We delve into the critical aspects of drug approval processes, marketing authorisations, and post-market surveillance, ensuring you stay informed on the latest regulatory updates and best practices. Equip yourself with the knowledge to tackle regulatory challenges head-on and deliver exceptional legal advice within the life sciences sector.
The Association of the British Pharmaceutical Industry (ABPI) has published a report calling for improved early warning systems to reduce medicines...
This week’s edition of Life Sciences weekly highlights includes news that the Health Research Authority (HRA) implemented updated operational guidance...
MedTech Europe has published a statement on Commission Implementing Regulation (EU) 2026/977, which introduces harmonised procedural requirements for...
MedTech Europe has published a paper outlining its position on the European Commission's proposal to reform the regulatory framework for medical...
Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...
Regulation of cosmetic products in the UKThis Practice Note provides an overview of the UK regulatory framework for cosmetics. It sets out the legal...
Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...
Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...
If a rentcharge is shown as being informally exonerated on title information, does this apply to the current registered owner? Or does the informal exoneration only apply to the parties to the document which informally exonerated the rentcharge?This Q&A considers the situation where, at some
If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit
Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an
Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of
0330 161 1234